Biomedical based development with breakthrough discoveries in acute and chronic (latter very similar to healing several fibroproliferative disorders) wound healing and clearing tissues form infection without using antibiotics. In need to gather funds for publishing 2 scientific papers and 1 patent:
- Acute and chronic wounds, their microenvironments and maladaptive inflammation.
- Maladaptive inflammation in Chronic Wounds
Paper n°2 needs a clinical study on pressure ulcers in order to demonstrate with statistical significancy efficacy of new treatment proposed in grade II/III ulcer resolution and reversal. Method has been used randomly in many chronic wounds with excellent results.
Paper n°1 is ready for printing and has in vitro, pre-clinical and clinical studies. Clinical study is on surgical wounds, none of which became infected in >150 patients.
A US patent is drafted but needs financial support.
Basic core permits a score of topical and transdermal products effective on skin and mucosal surfaces, either short or long term treatment. >10 products already fully tested. Problems as gum disease, acne, minor and major wounds, musculo/tendinous/joint pain, sprains, nail fungus, hemorrhoids, damaged hands for frequent washing, vaginosis are fully responsive to existing products. Surgical wounds as mentioned, do not get infected and evolve with minimal pain. Early pressure wounds are fully reversed. Our transdermal product Neumactil has un-precedented efficacy in asthma and COPD.
UN-PRECEDENTED SAFETY OF PRODUCTS.